Conheça alguns os estudos clínicos que já foram ou estão sendo realizados pela Science Valley:

TRATAMENTO

VALERIA TRIAL

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (VALERIA)

ClinicalTrials.gov Identifier: 
NCT04999176

SAIBA +

TRATAMENTO

COMPASS CLAUDICATION TRIAL

Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients

ClinicalTrials.gov Identifier: 
NCT04853719

SAIBA +

TRATAMENTO

VICTORION-2P TRIAL

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

ClinicalTrials.gov Identifier: 
NCT05030428

SAIBA +

TRATAMENTO

CRT-090 TRIAL

Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery

ClinicalTrials.gov Identifier: 
NCT03883763

SAIBA +

TRATAMENTO

CHARM TRIAL

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM)

ClinicalTrials.gov Identifier: 
NCT02864953

SAIBA +

TRATAMENTO

MICHELLE

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy

ClinicalTrials.gov Identifier: 
NCT04662684

SAIBA +    BAIXE O ESTUDO

TRATAMENTO

STRUCK TRIAL

Survival Trial Using CytoKines 

ClinicalTrials.gov Identifier: 
NCT04724629

SAIBA +

TRATAMENTO

BTK

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

ClinicalTrials.gov Identifier:
NCT04528667

SAIBA +

TRATAMENTO

COMET-ICE

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

ClinicalTrials.gov Identifier: 
NCT04545060

SAIBA +

PORTFÓLIO ESTRATÉGICO

AGRIPPA

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients

ClinicalTrials.gov Identifier: 
NCT04229264

SAIBA +